Paroxetine markedly increases plasma concentrations of ophthalmic timolol; cyp2d6 inhibitors may increase the risk of cardiovascular adverse effects of 0.5% timolol eye drops

Mäenpää J., Volotinen-Maja M., Kautiainen H., Neuvonen M., Niemi M., Neuvonen P.J., Backman J.T.

2014
Drug Metabolism and Disposition

View publication

Therapeutic Area

Glaucoma
Categories

Clinical development

Affiliations

Santen Oy, Tampere, Finland; Medcare Oy, Äänekoski, Finland; Department of Clinical Pharmacology, University of Helsinki, Helsinki University Central Hospital, P.O. Box 705, HUS, Helsinki, FI- 00029, Finland

Related Publications

Omidenepag Isopropyl 0.002% versus Latanoprost 0.005% in Open-Angle Glaucoma/Ocular Hypertension: The Randomized Phase III PEONY Trial

Wang T.H.; Aung T.; Lu D.-W.; George R.; Senthil S.; Lu F.; Odani-Kawabata N.; Park K.H.

Efficacy and Safety of a Preservative-Free Latanoprost Cationic Emulsion in Patients with Open-Angle Glaucoma and Concurrent Ocular Surface Disease: A Randomized Phase 2 Study.

Bacharach, Jason; McLaurin, Eugene B.; Silverstein, Steven; Amrane, Mourad; Garrigue, Jean-Sebastien; Ismail, Dahlia; Flynn, William J.; Catiolanze Phase 2 study group

Assessment of Brain-Derived Neurotrophic Factor on Retinal Structure and Visual Function in Rodent Models of Optic Nerve Crush

Taniguchi T.; Sharif N.A.; Ota T.; Farjo R.A.; Rausch R.

View all Glaucoma publications